lobbying_activities: 1594678

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1594678	c56633ad-de59-4e25-90ed-0102b861ea1e	Q3	BROWN RUDNICK LLP	287895	ZYDUS PHARMACEUTICALS USA INC.	2014	third_quarter	PHA	Issues relating to FDA generic drug approval; Generic Drug User Fee Amendments of 2012 (GDUFA)	HOUSE OF REPRESENTATIVES	30000		0	0	2014-10-17T15:44:16.187000-04:00